Bupropion Interference With Immunoassays for Amphetamines and LSD
- 1 June 2007
- journal article
- case report
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 29 (3) , 373-375
Abstract
A 50-year-old male patient suddenly had lost consciousness, although he had previously been healthy. On arrival at hospital seizures arose. The authors investigated a urine sample of the patient, and performed toxicological drug screening with immunochemical Cloned Enzyme Donor Immunoassay (CEDIA) assays. Positive findings for amphetamines and LSD could not be confirmed. Using gas chromatography/mass spectrometry (GC/MS), and liquid chromatography/mass spectrometry (LC/MS), the authors identified bupropion, a drug used to aid in smoking cessation, as the interfering compound, which may cause false-positive results for amphetamines and LSD using the CEDIA assays.Keywords
This publication has 4 references indexed in Scilit:
- Adverse Effects Associated with Extra Doses of BupropionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Sustained release bupropion overdose: an important cause of prolonged symptoms after an overdoseEmergency Medicine Journal, 2003
- Cardiotoxicity following Bupropion OverdoseAnnals of Pharmacotherapy, 2002
- Bupropion overdose: A 3-year multi-center retrospective analysisThe American Journal of Emergency Medicine, 1994